These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 30285832

  • 1. Notch2 signal is required for the maintenance of canine hemangiosarcoma cancer stem cell-like cells.
    Aoshima K, Fukui Y, Gulay KCM, Erdemsurakh O, Morita A, Kobayashi A, Kimura T.
    BMC Vet Res; 2018 Oct 03; 14(1):301. PubMed ID: 30285832
    [Abstract] [Full Text] [Related]

  • 2. Notch pathway inhibition targets chemoresistant insulinoma cancer stem cells.
    Capodanno Y, Buishand FO, Pang LY, Kirpensteijn J, Mol JA, Argyle DJ.
    Endocr Relat Cancer; 2018 Feb 03; 25(2):131-144. PubMed ID: 29175872
    [Abstract] [Full Text] [Related]

  • 3. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
    Liu J, Mao Z, Huang J, Xie S, Liu T, Mao Z.
    Biochem Biophys Res Commun; 2014 Feb 21; 444(4):670-5. PubMed ID: 24502949
    [Abstract] [Full Text] [Related]

  • 4. Honokiol inhibits melanoma stem cells by targeting notch signaling.
    Kaushik G, Venugopal A, Ramamoorthy P, Standing D, Subramaniam D, Umar S, Jensen RA, Anant S, Mammen JM.
    Mol Carcinog; 2015 Dec 21; 54(12):1710-21. PubMed ID: 25491779
    [Abstract] [Full Text] [Related]

  • 5. Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL.
    Hubmann R, Schnabl S, Araghi M, Schmidl C, Rendeiro AF, Hilgarth M, Demirtas D, Ali F, Staber PB, Valent P, Zielinski C, Jäger U, Shehata M.
    Cells; 2020 Jun 18; 9(6):. PubMed ID: 32570839
    [Abstract] [Full Text] [Related]

  • 6. Characteristics of Notch2(+) pancreatic cancer stem-like cells and the relationship with centroacinar cells.
    Zhou ZC, Dong QG, Fu DL, Gong YY, Ni QX.
    Cell Biol Int; 2013 Aug 18; 37(8):805-11. PubMed ID: 23536545
    [Abstract] [Full Text] [Related]

  • 7. Hemangiosarcoma and its cancer stem cell subpopulation are effectively killed by a toxin targeted through epidermal growth factor and urokinase receptors.
    Schappa JT, Frantz AM, Gorden BH, Dickerson EB, Vallera DA, Modiano JF.
    Int J Cancer; 2013 Oct 15; 133(8):1936-44. PubMed ID: 23553371
    [Abstract] [Full Text] [Related]

  • 8. Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis.
    Kumano K, Masuda S, Sata M, Saito T, Lee SY, Sakata-Yanagimoto M, Tomita T, Iwatsubo T, Natsugari H, Kurokawa M, Ogawa S, Chiba S.
    Pigment Cell Melanoma Res; 2008 Feb 15; 21(1):70-8. PubMed ID: 18353145
    [Abstract] [Full Text] [Related]

  • 9. Notch1 and Notch2 receptors regulate mouse and human gastric antral epithelial cell homoeostasis.
    Gifford GB, Demitrack ES, Keeley TM, Tam A, La Cunza N, Dedhia PH, Spence JR, Simeone DM, Saotome I, Louvi A, Siebel CW, Samuelson LC.
    Gut; 2017 Jun 15; 66(6):1001-1011. PubMed ID: 26933171
    [Abstract] [Full Text] [Related]

  • 10. Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy.
    Hayashi T, Gust KM, Wyatt AW, Goriki A, Jäger W, Awrey S, Li N, Oo HZ, Altamirano-Dimas M, Buttyan R, Fazli L, Matsubara A, Black PC.
    Clin Cancer Res; 2016 Jun 15; 22(12):2981-92. PubMed ID: 26769750
    [Abstract] [Full Text] [Related]

  • 11. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK, Kim MJ, Yoon CH, Lim EJ, Yoo KC, Lee GH, Kim YH, Kim H, Jin YB, Lee YJ, Cho CG, Oh YS, Gye MC, Suh Y, Lee SJ.
    Mol Pharmacol; 2012 Sep 15; 82(3):400-7. PubMed ID: 22648970
    [Abstract] [Full Text] [Related]

  • 12. Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.
    Yen WC, Fischer MM, Axelrod F, Bond C, Cain J, Cancilla B, Henner WR, Meisner R, Sato A, Shah J, Tang T, Wallace B, Wang M, Zhang C, Kapoun AM, Lewicki J, Gurney A, Hoey T.
    Clin Cancer Res; 2015 May 01; 21(9):2084-95. PubMed ID: 25934888
    [Abstract] [Full Text] [Related]

  • 13. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J, Tsujii M, Kondo J, Hayashi Y, Kato M, Akasaka T, Inoue T, Shiraishi E, Inoue T, Hiyama S, Tsujii Y, Maekawa A, Kawai S, Fujinaga T, Araki M, Shinzaki S, Watabe K, Nishida T, Iijima H, Takehara T.
    Int J Oncol; 2015 Apr 01; 46(4):1551-9. PubMed ID: 25625841
    [Abstract] [Full Text] [Related]

  • 14. High drug efflux pump capacity and low DNA damage response induce doxorubicin resistance in canine hemangiosarcoma cell lines.
    Morita A, Aoshima K, Gulay KCM, Onishi S, Shibata Y, Yasui H, Kobayashi A, Kimura T.
    Res Vet Sci; 2019 Dec 01; 127():1-10. PubMed ID: 31648115
    [Abstract] [Full Text] [Related]

  • 15. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
    Hsu EC, Kulp SK, Huang HL, Tu HJ, Salunke SB, Sullivan NJ, Sun D, Wicha MS, Shapiro CL, Chen CS.
    Neoplasia; 2015 Jun 01; 17(6):497-508. PubMed ID: 26152358
    [Abstract] [Full Text] [Related]

  • 16. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W, Gao Z, Duan Y, Yuan W, Ke Y.
    J Exp Clin Cancer Res; 2017 Mar 09; 36(1):41. PubMed ID: 28279221
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.
    Grudzien P, Lo S, Albain KS, Robinson P, Rajan P, Strack PR, Golde TE, Miele L, Foreman KE.
    Anticancer Res; 2010 Oct 09; 30(10):3853-67. PubMed ID: 21036696
    [Abstract] [Full Text] [Related]

  • 18. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
    Ponnurangam S, Dandawate PR, Dhar A, Tawfik OW, Parab RR, Mishra PD, Ranadive P, Sharma R, Mahajan G, Umar S, Weir SJ, Sugumar A, Jensen RA, Padhye SB, Balakrishnan A, Anant S, Subramaniam D.
    Oncotarget; 2016 Jan 19; 7(3):3217-32. PubMed ID: 26673007
    [Abstract] [Full Text] [Related]

  • 19. Inhibiting Notch Activity in Breast Cancer Stem Cells by Glucose Functionalized Nanoparticles Carrying γ-secretase Inhibitors.
    Mamaeva V, Niemi R, Beck M, Özliseli E, Desai D, Landor S, Gronroos T, Kronqvist P, Pettersen IK, McCormack E, Rosenholm JM, Linden M, Sahlgren C.
    Mol Ther; 2016 May 19; 24(5):926-36. PubMed ID: 26916284
    [Abstract] [Full Text] [Related]

  • 20. In vitro anticancer effects of alpelisib against PIK3CA‑mutated canine hemangiosarcoma cell lines.
    Maeda M, Ochiai K, Michishita M, Morimatsu M, Sakai H, Kinoshita N, Sakaue M, Onozawa E, Azakami D, Yamamoto M, Ishioka K, Sadahira T, Watanabe M, Tanaka Y.
    Oncol Rep; 2022 Apr 19; 47(4):. PubMed ID: 35234262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.